Biotechnology · Healthcare
Chief Accounting Officer
2021-05-20–present
Chief Accounting Officer
C4 Therapeutics, Inc. (CCCC)Equibles does not estimate personal net worth.
Get an email with a short summary when C4 Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get CCCC alertsWilliam T. McKee is recorded as Chief Accounting Officer at C4 Therapeutics, Inc. (CCCC) since May 20, 2021. The proxy statement of C4 Therapeutics, Inc. reports total compensation of $348,403 for William T. McKee in fiscal 2021. Disclosed compensation is on record for 3 fiscal years. C4 Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at C4 Therapeutics, Inc. includes Andrew J. Hirsch (CEO), Andrew Phillips (CEO), Ron Cooper (Chairman and Board Member) and 7 others.
2021-05-20–present
Start not stated–2022-04-29
Last confirmed by a filing; no departure on record
Biotechnology · Healthcare
Chief Accounting Officer
2021-05-20–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | C4 Therapeutics, Inc. (CCCC) | Former Chief Financial Officer | — | $348,403 |
| 2020 | C4 Therapeutics, Inc. (CCCC) | Former Chief Financial Officer | — | $2,099,745 |
| 2019 | C4 Therapeutics, Inc. (CCCC) | Chief Financial Officer | — | — |
No call appearances or filed executive changes recorded yet.